Korle-Bu Teaching Hospital is the health-care facility in Ghana. Located in the AblekumaSouth Metropolitan District in Accra. It is the only public tertiary hospital in the southern part of the country. It is a teaching hospital affiliated with the medical school of the University of Ghana.

There are 2,000 beds in Korle Bu Teaching Hospital.

During the past decade, Korle Bu Teaching Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Korle Bu Teaching Hospital" #1 sponsor was "University of Ghana Medical School" with 2 trials, followed by "Yale University" with 2 trials sponsored, "Allan Kember" with 1 trials sponsored, "Imara, Inc." with 1 trials sponsored and "International Atomic Energy Agency" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Korle Bu Teaching Hospital" #1 collaborator was "Korle-Bu Teaching Hospital, Accra, Ghana" with 5 trials as a collaborator, "University of Ghana" with 5 trials as a collaborator, "Kwame Nkrumah University of Science and Technology" with 3 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Korle Bu Teaching Hospital" are "HIV" (2 trials), "Postpartum Hemorrhage" (2 trials), "Sickle Cell Disease" (2 trials), "Acquired Immunodeficiency Syndrome" (1 trials) and "Autoinflammatory Syndrome, Unspecified" (1 trials). Many other conditions were trialed in "Korle Bu Teaching Hospital" in a lesser frequency.

Most popular intervention types in "Korle Bu Teaching Hospital" are "Behavioral" (6 trials), "Other" (6 trials), "Combination Product" (2 trials), "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Disclosure intervention" (2 trials), "usual care" (2 trials), "Body Position Sensor" (1 trials), "DESMOND" (1 trials) and "IMR-687" (1 trials). Other intervention names were less common.

The vast majority of trials in "Korle Bu Teaching Hospital" are 14 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Korle Bu Teaching Hospital". 2 are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Korle Bu Teaching Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Korle Bu Teaching Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".